{"entity":{"type":"insider","cik":"0001517309","url":"/insider/0001517309","json_url":"/insider/0001517309.json","name":"BERSANI PIETRO","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2024-06-12","last":"2024-08-26","span_basis":"filed_date"},"name_variants":[{"name":"BERSANI PIETRO","source":"filing","n_filings":2,"first_seen":"2024-06-12","last_seen":"2024-08-26"}],"transactions":[{"id":2451532,"accession":"0001437749-24-027784","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-027784","line_url":"/filing/0001437749-24-027784#line-2","is_derivative":false,"issuer_cik":"0001517309","issuer_name":"Kiromic Biopharma, Inc.","issuer_ticker":"KRBP","issuer_name_source":null,"issuer_url":"/issuer/0001517309","owner_cik":"0001517309","owner_name":"BERSANI PIETRO","owner_display_name":"BERSANI PIETRO","owner_url":"/insider/0001517309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":988.0,"shares_display":"988","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":1906.84,"total_display":"1,906.84","total_whole":"1,907","shares_owned_after":142333.0,"shares_owned_after_display":"142,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2451528,"accession":"0001437749-24-027784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-027784","line_url":"/filing/0001437749-24-027784#line-1","is_derivative":false,"issuer_cik":"0001517309","issuer_name":"Kiromic Biopharma, Inc.","issuer_ticker":"KRBP","issuer_name_source":null,"issuer_url":"/issuer/0001517309","owner_cik":"0001517309","owner_name":"BERSANI PIETRO","owner_display_name":"BERSANI PIETRO","owner_url":"/insider/0001517309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":5500.0,"total_display":"5,500.00","total_whole":"5,500","shares_owned_after":141345.0,"shares_owned_after_display":"141,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider"},{"id":2657035,"accession":"0001104659-24-070880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-070880","line_url":"/filing/0001104659-24-070880#line-2","is_derivative":false,"issuer_cik":"0001517309","issuer_name":"Kiromic Biopharma, Inc.","issuer_ticker":"KRBP","issuer_name_source":null,"issuer_url":"/issuer/0001517309","owner_cik":"0001517309","owner_name":"BERSANI PIETRO","owner_display_name":"BERSANI PIETRO","owner_url":"/insider/0001517309","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":9840.0,"total_display":"9,840.00","total_whole":"9,840","shares_owned_after":138845.0,"shares_owned_after_display":"138,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-12","scope":"insider"},{"id":2657027,"accession":"0001104659-24-070880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-070880","line_url":"/filing/0001104659-24-070880#line-1","is_derivative":false,"issuer_cik":"0001517309","issuer_name":"Kiromic Biopharma, Inc.","issuer_ticker":"KRBP","issuer_name_source":null,"issuer_url":"/issuer/0001517309","owner_cik":"0001517309","owner_name":"BERSANI PIETRO","owner_display_name":"BERSANI PIETRO","owner_url":"/insider/0001517309","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":9690.0,"total_display":"9,690.00","total_whole":"9,690","shares_owned_after":135845.0,"shares_owned_after_display":"135,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001792581","name":"Kiromic Biopharma, Inc.","url":"/issuer/0001792581","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2024-06-12","last_seen":"2024-08-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001517309","retrieved_at":"2026-08-25T19:05:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}